Skip to main content
Livermore
Livermore
ZHEN

BNP Paribas Arbitrage, SA

SEC CIK
0001166588
Latest filing
Aug 13, 2026

KZR holding history

Kezar Life Sciences, Inc. in every 13F filed by BNP Paribas Arbitrage, SA, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KZR overviewAll 13F holders of KZRFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of KZR by BNP Paribas Arbitrage, SA, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−89−100.0%Sold outHolders
Q1 202689$660<0.1%00.0%UnchangedHolders
Q4 202589$560<0.1%−7−7.3%ReducedHolders
Q3 202596$374<0.1%00.0%UnchangedHolders
Q2 202596$440<0.1%00.0%UnchangedHolders
Q1 202596$468<0.1%−13−11.9%ReducedHolders
Q4 2024109$732<0.1%+109NewHolders
Q3 20240$00.0%−443,724−100.0%Sold outHolders
Q2 2024443,724$266.2K<0.1%+170,294+62.3%AddedHolders
Q1 2024273,430$246.5K<0.1%+71,543+35.4%AddedHolders
Q4 2023201,887$191.3K<0.1%+118,088+140.9%AddedHolders
Q3 202383,799$99.7K<0.1%+66,508+384.6%AddedHolders
Q2 202317,291$42.4K<0.1%−85,262−83.1%ReducedHolders
Q1 2023102,553$321.0K<0.1%+31,163+43.7%AddedHolders
Q4 202271,390$502.6K<0.1%−43,155−37.7%ReducedHolders
Q3 2022114,545$986.2K<0.1%+98,066+595.1%AddedHolders
Q2 202216,479$136.3K<0.1%+11,973+265.7%AddedHolders
Q1 20224,506$74.9K<0.1%−9,021−66.7%ReducedHolders
Q4 202113,527$226.2K<0.1%+5,991+79.5%AddedHolders
Q3 20217,536$65.1K<0.1%+4,366+137.7%AddedHolders
Q2 20213,170$17.2K<0.1%−9,247−74.5%ReducedHolders
Q1 202112,417$74.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.